Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer
2020 · Cancer Chemotherapy and Pharmacology · 70 citations
https://doi.org/10.1007/s00280-020-04168-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
70
Citations
1
h-index
1
i10-index
Guoxiang Yu is an academic researcher from Shandong Provincial Hospital. The author has contributed to research in topics: Blood Pressure and Hypertension Studies & Cancer Cells and Metastasis & GaN-based semiconductor devices and materials. The author has an h-index of 1, co-authored 5 publications.
Click to start Chat